Skip to main content
Clinical Trials/NCT02069353
NCT02069353
Terminated
Not Applicable

Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest

Jonathan Elmer1 site in 1 country4 target enrollmentJuly 2015
ConditionsCardiac Arrest

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Arrest
Sponsor
Jonathan Elmer
Enrollment
4
Locations
1
Primary Endpoint
Occult Seizures
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

Cardiac arrest is the most common cause of death in the United States and as many as 590,000 Americans suffering a cardiac arrest each year. Despite advances in care, as many as 50 to 89% of patients who are resuscitated after a cardiac arrest die in the hospital. Brain injury is the most common cause of death and disability after cardiac arrest. The investigators use advanced brain monitoring in patients who are at high risk of death after cardiac arrest, with the goal of preventing ongoing brain injury. The most common problem the investigators have observed is low oxygen levels in the brain, which is often very difficult to treat.

In this study, the investigators plan to use two additional brain monitors in the care of these high risk patients: a monitor for seizures and a monitor of the amount of blood flow in the brain. The investigators will use these to detect and treat potential causes of low brain oxygen levels. The main hypotheses are that electrical events in the brain such as seizures and "spreading depolarizations" will occur during times of low brain tissue oxygen level, and that treating these events and low blood flow will reduce the rate of low brain oxygen levels.

Registry
clinicaltrials.gov
Start Date
July 2015
End Date
October 19, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

Jonathan Elmer

Assistant Professor, Department of Emergency Medicine

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • High risk survivors of cardiac arrest
  • Decision by potential subject's clinical team to use our institutional standard invasive, multimodal neurologic monitoring for post-arrest care

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Occult Seizures

Time Frame: Participants will be followed for the duration of invasive monitoring, an expected average of 5 days

Seizures detected by intracortical EEG but not surface EEG

Spreading Depolarizations

Time Frame: Participants will be followed for the duration of invasive monitoring, an expected average of 5 days

Cerebral Hypoperfusion

Time Frame: Participants will be followed for the duration of invasive monitoring, an expected average of 5 days

Secondary Outcomes

  • Monitor-associated Infection(Participants will be followed for the duration of the initial hospitalization, an expected average of 2 weeks)
  • Clinically Significant Bleeding(Participants will be followed for the duration of the initial hospitalization, an expected average of 2 weeks)
  • Device Malfunction(Participants will be followed for the duration of invasive monitoring, an expected average of 5 days)

Study Sites (1)

Loading locations...

Similar Trials